Famvir
Links shared publicly online about this topic
MediGuard.org - Famvir | Drug safety information | Monitoring more than 300 patients
mediguard.org — “MediGuard.org - Famvir | Drug safety information | Monitoring more than 300 patients” View full resource at mediguard.org
Most Recently Shared on March 10, 2011 at 8:17 pm By:
Real outcomes of 308 #famvir users tracking now on MediGuard.org, http://tinyurl.com/45c434c
Herpes Drugs Won't Raise Birth Defect Risk, Study Finds - Drugs.com MedNews
drugs.com — “Pregnant women who take antiviral drugs against the herpes virus should not worry that their use will cause birth defects, Danish researchers report. More than” View full resource at drugs.com
Most Recently Shared on August 25, 2010 at 5:19 am By:
Herpes Drugs Won't Raise Birth Defect Risk, Study Finds - http://bit.ly/d7SxLS
Herpes Drugs Won't Raise Birth Defect Risk, Study Finds:
health.msn.com — “Herpes Drugs Won't Raise Birth Defect Risk, Study Finds:” View full resource at health.msn.com
Most Recently Shared on August 24, 2010 at 8:44 pm By:
Herpes Drugs Won't Raise Birth Defect Risk, Study Finds: http://on.msn.com/991cwu
Watson Pharmaceuticals, Inc. | Investors |
ir.watson.com — “Watson Pharmaceuticals, Inc. | Investors |” View full resource at ir.watson.com
Most Recently Shared on March 22, 2011 at 2:21 pm By:
Watson introduces Famciclovir tablets to treat cold sores, genital herpes
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. has launched Famciclovir tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir following approval of its Abbreviated New Drug Application by the U.S. Food and Drug Administration.” View full resource at news-medical.net
Most Recently Shared on March 22, 2011 at 7:42 am By:
Medicare News: Watson introduces Famciclovir tablets to treat cold sores, genital herpes: Watson Pharmaceuticals... http://bit.ly/hap2Zf
Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis
news-medical.net — “Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.” View full resource at news-medical.net
Most Recently Shared on February 16, 2010 at 5:42 am By:
Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis: Teva Pharmaceutical Industries Ltd. ... http://bit.ly/c1hfYM
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MediGuard.org
Live health insights from 2.5+ million users of MediGuard, the easiest way to get safety alerts and recalls for your medicines.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
msn
Advertisement

